Analysis, commentary, and education from our team of market specialists. Covering global indices, equity markets, major economic events, and trading strategies.
All content is provided for informational and educational purposes only. Nothing published here constitutes financial advice or a recommendation to buy or sell any financial instrument.
Merck is beating the market year-to-date after a jump on positive Phase 3 data, while paying an annualized dividend of about $3.40 for a yield above 2.3%.
While investors pile into Nvidia, a quieter memory supplier has already outpaced it with gains toppi...
JBL's AI infrastructure growth and diversified portfolio are fueling gains, but supply chain risks a...
The Coca-Cola Company is widely known for its long history of paying and increasing dividends. I...
Concurrent Investment Advisors LLC lifted its stake in Analog Devices, Inc. (NASDAQ:ADI - Free Repor...
Similar moves in Europe and Japan reflect widening deficits and soaring debt, which are raising the ...
Shares are mostly higher in Asia after Nvidia and other technology stocks led an advance on Wall Str...
Markets continued to assess the implications of the Treasury's bond buyback plans, Trump's economic ...
Nebius’ innovative pricing and funding structure allows the company to maximise realized pricing w...
US stock futures fell on Tuesday as rising tensions between the US and Iran revived inflation concer...
Apple Inc.’s status as an anti-artificial intelligence play helped the stock tear through the firs...
Femasys CFO Dov Elefant has purchased approximately $50,000 worth of company stock, according to rec...
Airbnb CEO Brian Chesky has sold approximately $35 million worth of ABNB shares, according to recent...
We look at the chip sell-off that swept through Singapore's technology counters and the latest round...
Understandably, many investors fear another stock market meltdown. But history suggests the next one...
Create a free account to receive our weekly market analysis, trade insights, and exclusive strategy commentary directly from our research team.
For informational purposes only. Not financial advice. Trading involves significant risk of loss.
